Detalhe da pesquisa
1.
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
Cancer
; 125(4): 533-540, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570744
2.
A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma.
Br J Haematol
; 178(3): 434-441, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440559
3.
Optimal adaptive sequential designs for crossover bioequivalence studies.
Pharm Stat
; 15(1): 15-27, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538182
4.
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations.
Lung Cancer
; 190: 107512, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417277
5.
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial.
J Clin Transl Sci
; 7(1): e40, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36845310
6.
Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors.
Target Oncol
; 18(1): 105-118, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459255
7.
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'.
Pharm Stat
; 11(1): 8-13, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-21308974
8.
Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
Target Oncol
; 17(2): 125-138, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347559
9.
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).
Circ Arrhythm Electrophysiol
; 15(12): e010915, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441560
10.
Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome.
PLoS One
; 16(3): e0248739, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765021
11.
Metabolic effects of a growth hormone-releasing factor in patients with HIV.
N Engl J Med
; 357(23): 2359-70, 2007 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-18057338
12.
Sequential design approaches for bioequivalence studies with crossover designs.
Pharm Stat
; 7(4): 245-62, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17710740
13.
Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.
Cancer Chemother Pharmacol
; 81(2): 355-364, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29238851
14.
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
PLoS One
; 13(1): e0190849, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29320575
15.
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm.
J Am Coll Cardiol
; 72(5): 489-497, 2018 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049309
16.
Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
Target Oncol
; 17(2): 139, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380379
17.
Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects.
J Clin Pharmacol
; 46(6): 642-53, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16707411
18.
Suggestions for Streamlining and Optimizing Clinical End-Point Bioequivalence Studies for US Abbreviated New Drug Application Submissions.
Clin Pharmacol Ther
; 105(2): 310-312, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30430559
19.
Impact of Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 2(3): 237-45, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27121785
20.
Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.
AIDS
; 25(10): 1281-8, 2011 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21516030